NCT02076841 Tolerability and Quality of Life Study in Participants Who Switched to Avonex Pen Status COMPLETED Phase N/A
NCT02071121 Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of BIIB061 in Healthy Adult Volunteers Including Absolute Bioavailability and Food Effect Status COMPLETED Phase PHASE1
NCT02065375 RTA 408 Ophthalmic Suspension for the Treatment of Ocular Inflammation and Pain Following Ocular Surgery Status COMPLETED Phase PHASE2
NCT02052791 An Open-label Safety and Tolerability Study of Nusinersen (ISIS 396443) in Participants With Spinal Muscular Atrophy (SMA) Who Previously Participated in ISIS 396443-CS2 (NCT01703988) or ISIS 396443-CS10 (NCT01780246) Status COMPLETED Phase PHASE1
NCT02036970 Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIAT Status COMPLETED Phase PHASE2
NCT02029729 RTA 408 in the Treatment of Advanced Solid Tumors (NSCLC & Melanoma) - DISCOVER Status COMPLETED Phase PHASE1
NCT01978652 Pharmacokinetic Study of Peginterferon Beta-1a in Japanese and Caucasian Adult Healthy Participants. Status COMPLETED Phase PHASE1
NCT01955707 Effect of Natalizumab on Infarct Volume in Acute Ischemic Stroke Status COMPLETED Phase PHASE2
NCT01945359 Pilot Study to Assess Disease Stability in a Natalizumab to Dimethyl Fumarate Crossover Design Status COMPLETED Phase N/A
NCT01943513 A Study of the Effect of BIIB023 on Muscle Atrophy in Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT01939002 Characterize Flu-like Symptoms in Relapsing Multiple Sclerosis Patients Transitioning From Non-Pegylated Interferon Beta (IFN-β) Therapies to Peginterferon Beta-1a (BIIB017) Status COMPLETED Phase PHASE3
NCT01930890 BIIB023 Long-Term Extension Study in Subjects With Lupus Nephritis Status TERMINATED Phase PHASE2
NCT01930708 A Study Evaluating the Effectiveness of Tecfidera (Dimethyl Fumarate) on Multiple Sclerosis (MS) Disease Activity and Patient-Reported Outcomes Status COMPLETED Phase PHASE4
NCT01917019 A Safety and Efficacy Study of Oral Prolonged-Release Fampridine (BIIB041) in Japanese Participants With Multiple Sclerosis Status COMPLETED Phase PHASE3